UNC Hospitals Hillsborough
Hillsborough, NC
Accepting patients
Etentamig with Iberdomide
Phase 1/2 Study of Etentamig in Combination With a CELMoD Agent for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
- CELMoD
- Bispecific Antibody
- BCMA
- Phase 1